Intellia Therapeutics On Jun. 14 Entered Amendment To Collaborative Research Agreement With Novartis; Amendment Amends Novartis’ Rights With Respect To CAR-T Therapeutic Targets Under Agreement
On June 14, 2021, Intellia Therapeutics, Inc. (“Intellia”) entered into Amendment #3 (the “Amendment”) to its License and Collaborative Research Agreement (the “Collaboration
